Researchers from Virginia Commonwealth University (VCU) have introduced a novel method for detecting ovarian cancer by identifying specific biomarkers in urine samples. This development could lead to more accurate early diagnoses of the disease. The study, guided by Joseph Reiner, Ph.D., Professor and Chair of the Department of Physics at VCU’s College of Humanities and Sciences, utilized gold nanoparticles and nanopore sensing…
Innovate UK, the UK’s innovation agency, has awarded a significant grant of nearly £800,000 to a pioneering project, AI-VISION, aimed at advancing precision therapy in breast cancer treatment. This collaborative effort unites the expertise of cancer researchers from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, with cosmology and astrophysics specialists from the University of Durham, and…
US-based healthtech company DeepLook Medical has raised $1.7M to enhance cancer detection in dense breast tissue through advanced visual enhancement technology. The company has introduced a pioneering AI technology platform tailored for identifying suspicious masses in women with dense breasts. This innovation is significant as approximately 45% of women have dense breasts, which increases their risk of breast cancer. Traditional mammograms can…
Hologic has announced FDA clearance for its Genius Digital Diagnostics System, marking it as the first digital cytology system approved by the FDA that utilizes artificial intelligence (AI) and advanced imaging to enhance cervical cancer screening according to the company. The solution aims to improve the accuracy of detecting pre-cancerous lesions and cervical cancer cells, streamline workflow in laboratories, and elevate patient…
Matrix Health and Care has been granted a patent from the USPTO for Matrix, an innovative self-use pelvic assessment tool aimed at enhancing gynecological examinations. Distinct from traditional speculums, Matrix emphasizes patient comfort and control, allowing for self-administration in clinical settings and integrating real-time data transmission for clinical evaluation and research. The patent marks a significant milestone for Matrix Health & Care…
Teal Health is making strides in cervical cancer prevention with the SELF-CERV clinical study of its Teal Wand, an at-home self-collect device for cervical cancer screening. The study, underway at top health institutions such as Johns Hopkins, Yale University, and the University of Colorado, supports FDA submission and approval of the device. Teal Health’s initiative aims to provide a convenient and less…
Landing Med, a Chinese medtech company focused on early cancer detection, has achieved a significant milestone by completing over 10 million cervical cancer screenings using artificial intelligence (AI). Established by Dr. Xiaorong Sun, the company has been integrating automation, digital, AI, and cloud computing technologies into Pap smear testing across China since 2017. “I started Landing Med to address the challenge of…
Asieris Pharmaceuticals has launched a new Women’s Health Business Unit, focusing on advancing treatments in gynecology, particularly for cervical cancer. The initiative centers on APL-1702, a non-surgical treatment for cervical high-grade squamous intraepithelial lesions, positioning the company at the forefront of innovative gynecological care. This move aligns with global health initiatives aimed at combating cervical cancer. The China National Program for Women’s…
